Moderna has a P/B ratio of 1.25. This indicates that the market value of the company exceeds its book value by a factor of ...

The S&P 500 fell 0.1% on Tuesday, July 8, 2025, after President Trump extended the deadline for "reciprocal" tariffs and ...

Moderna (MRNA), an undervalued name in the biotech space, rose to prominence during the COVID-19 pandemic. This occurred when ...

View the latest Moderna Inc. (MRNA) stock price, news, historical charts, analyst ratings and financial information from WSJ.

According to the CDC, there has been a decline in animal infections and no reports of human cases since February.

The U.S. Centers for Disease Control and Prevention ended its emergency response for bird flu as the outbreak that sickened ...

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

The U.S. Centers for Disease Control and Prevention has ended its emergency response to the H5N1 bird flu outbreak, a move ...

The capped upside and unlimited downside risk make MRNY unattractive unless Moderna's share price stabilizes and recovers ...

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

Hearing aids dramatically improve a person's social engagement and reduce feelings of isolation or loneliness, based on ...